We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
29 hedge funds and large institutions have $3.84M invested in CASI Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
20% more capital invested
Capital invested by funds: $3.21M → $3.84M (+$629K)
3% less funds holding
Funds holding: 30 → 29 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Holders
29
Holders Change
-1
Holders Change %
-3.33%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$364K |
| 2 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
+$22.6K |
| 3 |
Renaissance Technologies
New York
|
+$10.5K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.48K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$6.47K |
Top Sellers
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$25K |
| 2 |
WSC
Wellington Shields & Co
New York
|
-$23.2K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$16K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$5.92K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.5K |
